BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/13/2026 7:25:30 AM | Browse: 2 | Download: 0
 |
Received |
|
2026-01-23 02:38 |
|
Peer-Review Started |
|
2026-01-23 02:46 |
|
First Decision by Editorial Office Director |
|
2026-01-28 09:11 |
|
Return for Revision |
|
2026-01-28 09:11 |
|
Revised |
|
2026-01-30 19:20 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-25 02:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-25 07:31 |
|
Articles in Press |
|
2026-02-25 07:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-16 08:12 |
|
Publish the Manuscript Online |
|
2026-08-13 07:25 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Enhancing renin-angiotensin-aldosterone system inhibitors utilization through patiromer adherence - real-world insights for nephrology practice
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Gemechu Dereje Feyissa |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gemechu Dereje Feyissa, Assistant Professor, Department of Public Health, Faculty of Health Sciences, Rift Valley University, Hangatu District, Dabe Sub-City, Adama 1715, Oromīa, Ethiopia. gemechudereje80@gmail.com |
| Key Words |
Renin-angiotensin aldosterone system inhibitors; Patiromer adherence; Hyperkalemia management; Chronic kidney disease; Nephrology practice |
| Core Tip |
Among 13447 real-world patiromer users, high adherence [proportion of days covered (PDC) ≥ 80%] drove approximately 10% higher renin-angiotensin-aldosterone system inhibitors utilization (Table 1). Prioritize chronic patiromer (Kidney Disease: Improving Global Outcomes 2021/OPAL-HK), monitor PDC, use multidisciplinary support to overcome barriers, and combine with SGLT2i/finerenone for renal/cardiovascular protection. |
| Publish Date |
2026-08-13 07:25 |
| Citation |
Feyissa GD. Letter to the Editor: Enhancing renin-angiotensin-aldosterone system inhibitors utilization through patiromer adherence - real-world insights for nephrology practice. World J Nephrol 2026; 15(3): 119286
|
| URL |
https://www.wjgnet.com/2220-6124/full/v15/i3/119286.htm |
| DOI |
https://doi.org/10.5527/wjn.119286 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
